Changes in liver stiffness measurements following hepatitis C sustained virologic response among Alaska Native adults treated with sofosbuvir-based direct acting anti-viral therapy

Direct-acting antiviral (DAA) hepatitis C treatment can reduce fibrosis and prevent cirrhosis and its sequelae. This study aims to evaluate changes in fibrosis and lab measurements from pre-treatment to post-treatment and over time following the end-of-treatment among Alaska Native and American Indi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Janet M. Johnston, Lisa Townshend-Bulson, Brian McMahon, Dana Bruden, Chriss Homan, Kena Desai, Wileina Rhodes, Youssef Barbour
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	International Journal of Circumpolar Health
Assuntos:	Hepatitis C direct acting antiviral therapy Alaska Native fibrosis Vibration-Controlled Transient Elastography (VCTE)
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/22423982.2025.2535044
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!